Cipher Pharmaceuticals

230 articles with Cipher Pharmaceuticals

• Notice of Cipher Pharmaceuticals Annual Meeting of Shareholders

  4/1/2008

• Cipher Pharmaceuticals Reports Fiscal 2007 Year-end Results

  2/27/2008

• Notice of Cipher Pharmaceuticals Fiscal 2007 Fourth Quarter and Year End Conference Call

  2/20/2008

• Cipher Pharmaceuticals Provides CIP-TRAMADOL ER Regulatory Update

  2/11/2008

• Cipher Pharmaceuticals Receives FDA Response to CIP-TRAMADOL ER Appeal

  2/1/2008

• Cipher Pharmaceuticals Provides Product Update

  1/8/2008

• Cipher Pharmaceuticals Appoints Stefan Aigner to Board of Directors

  12/6/2007

• Cipher Pharmaceuticals Appeals FDA's Decision On CIP-TRAMADOL

  12/5/2007

• Cipher Pharmaceuticals Reports Third Quarter Fiscal 2007 Results

  11/7/2007

• Notice of Cipher Pharmaceuticals Fiscal 2007 Third Quarter Conference Call

  10/22/2007

• Cipher Pharmaceuticals Appoints William C. Garriock Chairman of the Board of Directors

  10/17/2007

• Cipher Pharmaceuticals Mourns Passing of Director Waldemar Zimmerman

  9/10/2007

• Notice of Cipher Pharmaceuticals Fiscal 2007 Second Quarter Conference Call

  7/13/2007

• Cipher Pharmaceuticals Enters into U.S. Licensing and Distribution Agreement for Lipofen

  7/10/2007

• Cipher Pharmaceuticals Receives Approvable Letter from FDA for CIP-ISOTRETINOIN; FDA Seeks More Clinical Data

  4/27/2007

• Cipher Pharmaceuticals Annual and Special Meeting of Shareholders

  4/13/2007

• Cipher Pharmaceuticals Reports Fiscal 2006 Year-end Results

  3/7/2007

• Notice of Cipher Pharmaceuticals Conference Call

  2/27/2007

• Cipher Pharmaceuticals's Response To Approvable Letter For CIP-ISOTRETINOIN Accepted For Review By FDA

  1/17/2007

• Notice Of Cipher Pharmaceuticals Conference Call

  10/26/2006